Safe medication administration: a guide for nursing students

Medication errors are one of the most common — and most preventable — adverse events in healthcare. The Institute of Medicine estimated that medication errors harm at least 1.5 million people annually in the United States, and nurses are at the center of the final check. You receive the order, verify the drug, calculate the dose, select the route, prepare the medication, and deliver it to the patient. Every one of those steps carries an opportunity to catch an error before it causes harm.

This guide covers what nursing students need to know about safe medication administration: routes and technique, injection site selection, high-alert medications, documentation requirements, and the clinical nuances that appear on the NCLEX. For a focused breakdown of the rights of medication administration, see our medication rights guide.

Route comparison: fast-scan reference

Routes of administration

Oral (PO)

Oral medications are absorbed through the GI tract and are subject to first-pass hepatic metabolism, which reduces bioavailability compared to parenteral routes. The oral route is the most common, the safest, and the most convenient — but it requires that the patient is conscious, has an intact swallow reflex, and has a functional GI tract.

Crushing medications is a frequent source of errors. Before crushing any tablet, always verify against the facility’s “Do Not Crush” list. Never crush:

• Extended-release, sustained-release, or controlled-release formulations (labeled SR, ER, XL, XR, CR, LA, CD)
• Enteric-coated tablets (dissolve in intestine, not stomach)
• Sublingual or buccal formulations
• Cytotoxic agents (crush creates inhalation hazard)
• Capsules designed to protect the stomach from the drug content

Scored tablets may be halved along the score line — but confirm that the specific formulation is appropriate to split before doing so.

Sublingual vs. buccal positioning: Sublingual medications (nitroglycerin, lorazepam SL) go under the tongue and absorb through the highly vascular floor of the mouth. The patient should not swallow, eat, or drink until the tablet dissolves. Buccal medications are placed between the cheek and gum. Both routes bypass hepatic first-pass metabolism and act faster than swallowed tablets.

Intramuscular (IM)

IM injection delivers medication directly into muscle tissue, where absorption occurs via muscle vascularity. Onset is faster than oral but slower than IV. The technique and site selection matter significantly for both safety and drug absorption.

Injection angle and equipment: IM injections are given at a 90° angle. Needle gauge is typically 21–23 G; length is 1–1.5 inches for most adults (longer for obese patients — up to 2 inches for the ventrogluteal site in morbidly obese adults). Draw the medication, change the needle if the medication is irritating, then administer.

Z-track technique is required for medications that stain the skin (iron dextran) or cause irritation if they leak into subcutaneous tissue. Pull the skin 2.5–3.5 cm laterally, insert at 90°, inject slowly, wait 10 seconds, then release the skin. This creates a zigzag path through tissue layers that seals the medication in. For full technique detail, see our Z-track method guide.

Aspiration for IM injections: Traditional practice required aspirating before injecting to confirm needle placement outside a vessel. Current evidence from the WHO, CDC, and nursing literature does not support routine aspiration for IM injections at recommended sites — there are no large blood vessels at ventrogluteal or deltoid landmarks. However, some facilities still include aspiration in their protocols. Follow your institution’s policy.

Subcutaneous (SQ)

Subcutaneous injections deposit medication into the fatty tissue layer beneath the dermis. Absorption is slower than IM due to lower vascularity. Common SQ medications include insulin, heparin, enoxaparin, and some vaccines.

Injection sites (order of preference): abdomen (fastest absorption, avoid 2-inch radius around umbilicus), outer thigh, upper outer arm. Rotate sites with every injection to prevent lipodystrophy — a hardening of subcutaneous tissue that impairs absorption. Consistent use of the same area (common with insulin self-injection) leads to erratic drug levels over time.

Angle: 90° for most patients with adequate subcutaneous tissue; 45° for very thin patients to avoid hitting muscle. Pinch a skin fold to elevate subcutaneous tissue, especially in thin patients.

Volume: maximum 1 mL per SQ injection.

Intravenous (IV)

IV medications enter the bloodstream directly, producing the fastest onset. They are also the highest-risk route — there is no recall once injected. For IV site selection, catheter gauge, and insertion procedure, see our IV insertion guide.

IV push (bolus): Medication is injected directly into the IV line or saline lock over a specified time (e.g., “give over 2 minutes”). Always flush the line with normal saline before and after to verify patency and clear residual medication from the tubing. Check drug compatibility with any running infusion before pushing through the same line.

IV piggyback (IVPB): A secondary bag (typically 50–250 mL) connected to the primary IV line via secondary tubing. The secondary bag is hung higher than the primary bag so it infuses first by gravity; the primary resumes when the secondary is empty. Most IVPB medications run over 30–60 minutes on an infusion pump.

Compatibility: Always check drug-drug and drug-fluid compatibility before infusing through the same line. Incompatible combinations can precipitate in the line, deliver a degraded drug, or cause the patient direct harm.

Topical and transdermal

Topical medications (creams, ointments, gels) act locally at the skin surface with minimal systemic absorption. Transdermal patches deliver drugs systemically through the skin over hours to days.

Patch application protocol:

1. Don gloves — this applies to application and removal. Many transdermal drugs (nitroglycerin, fentanyl, scopolamine) absorb through the nurse’s skin as readily as the patient’s.
2. Remove the old patch. Document its removal. This is a patient safety step — retained patches cause drug accumulation and toxicity.
3. Fold the old patch adhesive-side in before disposal.
4. Clean the skin site, allow to dry, and apply the new patch to a different site.
5. Date, time, and initial the new patch.
6. Document both the old patch removal and new patch placement.

Rotate sites with each application and select skin that is dry, intact, and free of hair. Avoid areas with cuts, rashes, or skin folds that alter absorption.

Ophthalmic

Eye drops are instilled into the lower conjunctival sac — not directly onto the cornea. Have the patient tilt the head back and look up. Pull the lower lid down gently to form a pocket, instill the prescribed number of drops, and release the lid. Avoid touching the dropper tip to the eye or eyelid (contamination risk).

Apply gentle pressure to the nasolacrimal duct (inner corner of the eye) for at least one minute after instillation. This occlusion prevents the drop from draining into the nasal passages and being systemically absorbed — relevant for beta-blocker eye drops (timolol) that can cause bradycardia and bronchospasm if absorbed systemically.

When two different eye drops are ordered for the same eye, wait at least five minutes between instillations to prevent the second drop from washing out the first.

Otic

Ear drops are instilled with the patient lying on the unaffected side (affected ear up). The pinna (outer ear) must be pulled to straighten the ear canal:

• Adults and children over approximately age 3: pull the pinna up and back
• Infants and young children: pull the pinna down and back

After instilling drops, keep the patient on the unaffected side for 2–5 minutes, then insert a loose cotton ball if ordered. Warm the drops to body temperature if possible — cold drops can cause dizziness by stimulating the semicircular canals.

Nasal and inhaled

Nasal spray: Position the tip in the nostril and angle it away from the nasal septum to avoid damage. Instruct the patient to sniff gently during actuation, not to blow the nose immediately after, and to breathe through the mouth.

Metered-dose inhalers (MDI): Shake the inhaler, have the patient exhale fully, actuate at the beginning of a slow deep inhalation, and instruct them to hold the breath for 10 seconds. A spacer (valved holding chamber) significantly improves drug delivery — particularly for patients who have trouble coordinating inhalation with actuation, including children and older adults. After using corticosteroid inhalers, have the patient rinse the mouth and gargle to prevent oropharyngeal candidiasis.

Dry powder inhalers (DPI): Do not shake — shaking disperses the powder. Load the dose, exhale away from the device, then inhale rapidly and forcefully (DPIs require faster inspiratory flow than MDIs).

IM injection site selection

Site selection determines both safety and effective drug delivery. The correct site depends on the patient’s age, muscle mass, volume to be injected, and the specific medication.

The shift away from the dorsogluteal site is one of the most important evidence-based changes in injection practice. The sciatic nerve runs through the lower gluteal region, and even careful upper-outer-quadrant placement carries a risk that the ventrogluteal site eliminates entirely. NCLEX questions frequently test this distinction.

High-alert medications

High-alert medications are drugs that carry a significantly elevated risk of causing serious patient harm when used in error. The Institute for Safe Medication Practices (ISMP) maintains a formal high-alert medications list. These drugs may not cause harm more often than others — but when they do cause harm, the consequences are severe.

Independent double-check means two licensed nurses verify the order, drug, dose, route, rate, and pump settings independently — without comparing notes first. The second nurse checks the primary nurse’s work separately, then they compare findings. A shared check where one nurse simply confirms what the other has already read is not an independent double-check and does not carry the same protective value.

Safe administration principles

MAR documentation

The Medication Administration Record (MAR) is the legal record of what was given, when, and by whom. The cardinal rule: document after administering, never before. Pre-documentation — signing off a medication before it is given — has contributed to patient deaths and is a serious nursing violation. If you chart a medication as given and then are interrupted before administering it, the patient may receive a double dose when the next nurse sees it as already documented.

Verify the MAR against the pharmacy label at three points: when you remove the medication from the dispensing system, when you prepare it, and immediately before you administer it to the patient. This three-label check is a safeguard against wrong-drug and wrong-dose errors.

Three-label check

1. When removing the medication from the storage location (medication cabinet, automated dispensing unit)
2. When preparing the medication (drawing up, reconstituting, or setting up the infusion)
3. Immediately before administration — at the patient’s bedside, verify against the MAR one final time

Single-dose vs. multi-dose vials

Single-dose vials contain no preservative and are intended for one patient and one use. Discard after use even if medication remains. Multi-dose vials contain preservatives to inhibit microbial growth. Date the vial when it is first opened — facility policy and manufacturer guidelines specify the in-use period, typically a maximum of 28 days from first puncture, regardless of how much medication remains. Discard at 28 days or the manufacturer’s expiration date, whichever comes first.

Reconstitution

When reconstituting a powder for injection, add the specified diluent (sterile water for injection, normal saline, or the manufacturer-specified diluent — these are not interchangeable for all drugs) in the volume directed. Swirl gently rather than shaking vigorously to avoid foaming. After reconstitution, verify the resulting concentration before drawing up the dose. Label the vial with date, time, resulting concentration, and your initials.

Controlled substance management

Controlled substances require:

• Co-signature at removal: a second licensed nurse witnesses the drug removal from the automated dispensing unit and co-signs the retrieval
• Witness for waste: if only part of a dose is used, the remaining portion must be wasted in the presence of a witness who co-signs the documentation
• Count reconciliation: controlled substance counts are performed at each shift change; discrepancies must be reported immediately and not carried forward

Medication reconciliation

Medication reconciliation — systematically comparing a patient’s current medications against orders at every care transition — is a Joint Commission patient safety goal. Reconciliation occurs at admission (compare home medications to admission orders), transfer (compare unit-to-unit medication orders), and discharge (compare discharge orders to pre-admission and inpatient medications, and provide patient education).

For a broader look at pharmacology categories relevant to clinical practice, see our drug classifications guide and the nursing pharmacology reference.

Medications never to crush

NCLEX tips: 15 high-yield discriminators

These are the clinical nuances that appear most frequently in NCLEX medication administration questions. Each one represents a point where a common assumption leads to the wrong answer.

1. Ventrogluteal, not dorsogluteal. The ventrogluteal site is the preferred IM injection site for adults. The dorsogluteal site carries a risk of sciatic nerve injury and is no longer recommended by current evidence or most nursing organizations.

2. Vastus lateralis for infants. Children under 12 months should receive IM injections in the vastus lateralis. The ventrogluteal site requires adequate gluteal muscle development — not present in early infancy.

3. Deltoid volume limit is 1 mL. Never exceed 1 mL in the deltoid muscle — it is small and poorly tolerates larger volumes. Vaccine programs administer 0.5 mL; exceeding 1 mL risks injury.

4. Never crush extended-release medications. If the NCLEX presents a scenario where a patient can’t swallow a whole tablet and the medication is labeled XR, SR, ER, or XL — the correct action is to contact the prescriber or pharmacist, not to crush it.

5. MAR documentation is always after administration, never before. Pre-charting is a safety violation. If a question describes documenting before giving a medication, that is incorrect practice.

6. KCl IV push causes cardiac arrest. Concentrated potassium chloride must be diluted before IV administration. The maximum safe rate for peripheral infusion is 10 mEq/hr; central administration (with continuous monitoring) may go up to 20 mEq/hr. IV push is never acceptable.

7. U-500 insulin requires a U-500 syringe. U-500 is five times more concentrated than standard U-100 insulin. Drawing U-500 in a U-100 syringe results in a 5× overdose. U-500 requires its own dedicated syringe or an insulin pump programmed for U-500.

8. Independent double-check is truly independent. Two nurses verify separately. One nurse reading aloud while the other agrees does not constitute an independent double-check.

9. Transdermal patch removal is a clinical safety step. The NCLEX will present scenarios where the old patch was not removed. The right answer always includes verifying and documenting old patch removal — not just applying the new one.

10. Ophthalmic drops go in the lower conjunctival sac. Not directly on the cornea — that is painful and reflexively washed away. The conjunctival sac holds the drop and allows absorption. Apply gentle pressure to the nasolacrimal duct to reduce systemic absorption.

11. Otic pinna direction reverses by age. Adults and older children: pull pinna up and back. Infants and young children: pull pinna down and back. The reversal straightens the anatomically different ear canal in younger children.

12. Aspiration for IM is not universally required. Current evidence does not support routine aspiration at recommended IM sites (ventrogluteal, vastus lateralis, deltoid). However, follow your facility’s protocol — some facilities still require it. If the NCLEX question specifies the institutional policy requires aspiration, that is the correct answer in context.

13. Multi-dose vials expire 28 days from first use. This is the ISMP and CDC default recommendation. The original expiration date on the vial label applies only to unopened vials. Once punctured, the 28-day clock starts.

14. Controlled substance waste requires a witness. If a vial contains 10 mg and only 8 mg is ordered, the remaining 2 mg must be wasted in front of a licensed co-signer. The correct action when waste is undocumented is not to carry it forward — it is to follow reporting procedures.

15. Medication reconciliation happens at every transition. Admission, transfer between units, and discharge each require a formal reconciliation. The most dangerous transitions for omission errors are discharge (many patients have new medications and discontinued home medications) and transfer to a lower-acuity setting.

Clinical sources

• Institute for Safe Medication Practices (ISMP). ISMP List of High-Alert Medications in Acute Care Settings. ismp.org
• World Health Organization. WHO Best Practices for Injections and Related Procedures Toolkit. WHO Press, 2010.
• Centers for Disease Control and Prevention. Injection Safety. cdc.gov/injectionsafety
• National Council of State Boards of Nursing (NCSBN). NCLEX-RN Test Plan. ncsbn.org
• The Joint Commission. National Patient Safety Goals. jointcommission.org
• Nicoll, L.H., & Hesby, A. (2002). Intramuscular injection: an integrative research review and guideline for evidence-based practice. Applied Nursing Research, 16(2), 149–162.
• Ogston-Tuck, S. (2014). Intramuscular injection technique: an evidence-based approach. Nursing Standard, 29(4), 52–59.
• Crawford, P., & Johnson, A. (2012). Ventrogluteal versus dorsogluteal site selection for intramuscular injection. American Journal of Nursing, 112(1), 10–11.
• American Nurses Association. Medication Administration: Rights and Safety. nursingworld.org